SCHEMBL24964382

SCHEMBL24964382

c1ccc(N(c2ccc(-c3ccc(-c4cccc5ccccc45)cc3)cc2)c2ccc3c(c2)oc2ccccc23)c(-c2ccc3c(c2)oc2ccccc23)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCL1 Q07820 1/20 0.36
▸ ACMSD Q8TDX5 1/20 0.36
▸ ALOX5 P09917 1/20 0.36
▸ CA12 O43570 2/20 0.36
▸ CA1 P00915 2/20 0.36
▸ CA2 P00918 2/20 0.36
▸ CA9 Q16790 2/20 0.36
▸ DUSP3 P51452 1/20 0.35
▸ AHR P35869 2/20 0.35
▸ PRKDC P78527 1/20 0.34
▸ KDM4E B2RXH2 3/20 0.34
▸ ALDH1A1 P00352 3/20 0.34
▸ MAPT P10636 3/20 0.34
▸ HPGD P15428 2/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ ENPP3 O14638 1/20 0.34
▸ ENPP1 P22413 1/20 0.34
▸ HCRTR1 O43613 1/20 0.33
▸ MMP12 P39900 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24964444 0.99 MCL1 (0.37) MCL1ACMSDALOX5CA12CA1
SCHEMBL24962807 0.98 ALOX5 (0.38) MCL1ACMSDALOX5CA12CA1
SCHEMBL23233440 0.96 CA12 (0.39) MCL1ACMSDALOX5CA12CA1
SCHEMBL24965107 0.96 CA12 (0.39) MCL1ACMSDALOX5CA12CA1
SCHEMBL23232859 0.96 ALOX5 (0.39) MCL1ACMSDALOX5CA12CA1
SCHEMBL24965578 0.95 MCL1 (0.35) MCL1ACMSDALOX5CA12CA1
SCHEMBL23238552 0.95 CA12 (0.37) MCL1ACMSDALOX5CA12CA1
SCHEMBL23233075 0.95 MCL1 (0.35) MCL1ACMSDALOX5CA12CA1
SCHEMBL24963844 0.95 CA12 (0.38) MCL1ACMSDALOX5CA12CA1
SCHEMBL23233005 0.95 MCL1 (0.36) MCL1ACMSDALOX5CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230026162-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026162-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE L1CAM, LEF1, MLX MCL1 3058/4885ACMSD 2451/4885ALOX5 1391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback